Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4738 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4745 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-147 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-22 |
filingDate |
2000-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2008-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2008-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-100794417-B1 |
titleOfInvention |
10,11-difluoromethylenedioxycamptothecin compound with topoisomerase I inhibitory activity |
abstract |
Camptothecin compounds having a C 10 , 11 O- (CF 2 ) n O group in which n is 1 or 2 are effective antitumor compounds. These compounds inhibit the enzyme topoisomerase I and can alkylate the DNA of the bound topoisomerase I-DNA degradable complex.n n n n 10,11-difluoromethylenedioxycamptothecin compound, anti-tumor compound, topoisomerase I, topoisomerase I-DNA degradable complex |
priorityDate |
1999-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |